Case Reports
doi: 10.1001/archderm.136.11.1415.
Intralesional interferon alfa for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis
- PMID: 11074712
- DOI: 10.1001/archderm.136.11.1415
Item in Clipboard
Case Reports
Intralesional interferon alfa for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis
Arch Dermatol.
2000 Nov.
Erratum in
- Arch Dermatol 2001 Jan;137(1):29
No abstract available
Similar articles
-
Intralesional interferon treatment of lentigo maligna.Arch Dermatol. 2000 Mar;136(3):428-30. doi: 10.1001/archderm.136.3.428. Arch Dermatol. 2000. PMID: 10724220 No abstract available.
-
Periocular lentigo maligna treated with imiquimod.J Dermatolog Treat. 2011 Apr;22(2):109-12. doi: 10.3109/09546630903559798. Epub 2010 Jul 28. J Dermatolog Treat. 2011. PMID: 20666668
-
Five-year recurrence rate of lentigo maligna after off-label treatment with imiquimod.Br J Dermatol. 2016 Jan;174(1):22-3. doi: 10.1111/bjd.14259. Br J Dermatol. 2016. PMID: 26790655 No abstract available.
-
Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology.J Surg Oncol. 2004 Jul 1;86(4):179-86. doi: 10.1002/jso.20081. J Surg Oncol. 2004. PMID: 15221924 Review.
-
[Imiquimod in the treatment of lentigo maligna].Actas Dermosifiliogr. 2011 Oct;102(8):559-62. doi: 10.1016/j.ad.2011.03.003. Epub 2011 May 4. Actas Dermosifiliogr. 2011. PMID: 21536245 Review. Spanish. No abstract available.
Cited by
-
Topical and Intralesional Immunotherapy for the Management of Skin Cancer in Special Locations: Lips and Eyelids.Cancers (Basel). 2023 Oct 17;15(20):5018. doi: 10.3390/cancers15205018. Cancers (Basel). 2023. PMID: 37894385 Free PMC article. Review.
-
Topical and Intralesional Immunotherapy for Melanoma In Situ: A Review.Cancers (Basel). 2023 Sep 8;15(18):4468. doi: 10.3390/cancers15184468. Cancers (Basel). 2023. PMID: 37760438 Free PMC article. Review.
-
Interferon alpha for the treatment of melanocytic conjunctival lesions.Graefes Arch Clin Exp Ophthalmol. 2010 Jan;248(1):111-5. doi: 10.1007/s00417-009-1189-0. Epub 2009 Sep 15. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 19756691
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
